Literature DB >> 4054131

Activation of phosphatidylcholine-sterol acyltransferase by human apolipoprotein E isoforms.

A Steinmetz, H Kaffarnik, G Utermann.   

Abstract

The reaction catalysed by phosphatidylcholine-sterol acyltransferase (EC 2.3.1.43) is believed to be the major source of cholesteryl ester in human plasma; the enzyme requires a protein activator. Several human apolipoproteins were found to exhibit an activator function, the major one being apolipoprotein A-I. Human apolipoprotein E exists in the population mainly in three different genetic isoforms; apolipoprotein E-2, E-3 and E-4. These isopeptides were isolated from subjects homozygous for one of the isoforms, incorporated into phospholipid/cholesterol/[14C]cholesterol complexes by the cholate dialysis procedure and used to measure capacity to activate phosphatidylcholine-sterol acyltransferase in comparison to apolipoprotein A-I lipid substrate particles prepared by the same procedure. Acyltransferase activity was measured by the formation of [14C]cholesteryl ester from [14C]cholesterol using purified enzyme. With egg yolk phosphatidylcholine as acyl donor, apo E was 15-19% as efficient as apolipoprotein A-I for activation of the acyltransferase. Apo-E-stimulated cholesteryl ester formation by the enzyme was enhanced when 1-oleoyl-2-palmitoyl-glycerophosphocholine was used as a substrate phospholipid (45% of apo A-I/phosphatidylcholine control) and most pronounced with dimyristoylglycerophosphocholine (75% of apo A-I/phosphatidylcholine control). No significant difference in activation was found between apo E isoforms. It is concluded that apolipoprotein E activates phosphatidylcholine-sterol acyltransferase in vitro and that apolipoprotein E isoforms are similarly effective.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4054131     DOI: 10.1111/j.1432-1033.1985.tb09256.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.

Authors:  Kyriakos E Kypreos; Vassilis I Zannis
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

2.  Domains of apoE4 required for the biogenesis of apoE-containing HDL.

Authors:  Alexander M Vezeridis; Angeliki Chroni; Vassilis I Zannis
Journal:  Ann Med       Date:  2011-06       Impact factor: 4.709

3.  Sequence-specific apolipoprotein A-I effects on lecithin:cholesterol acyltransferase activity.

Authors:  Alexander D Dergunov
Journal:  Mol Cell Biochem       Date:  2013-03-21       Impact factor: 3.396

4.  Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma.

Authors:  Y Zhu; S Bellosta; C Langer; F Bernini; R E Pitas; R W Mahley; G Assmann; A von Eckardstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.